Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain ; volume:14 ; number:1 ; day:12 ; month:11 ; year:2022 ; pages:1-9 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (12.11.2022), 1-9, 12.2022
- Creator
-
Mar, Javier
Ibarrondo, Oliver
Larrañaga, Igor
Mar-Barrutia, Lorea
Soto-Gordoa, Myriam
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01111-7
- URN
-
urn:nbn:de:101:1-2023012621011207652787
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mar, Javier
- Ibarrondo, Oliver
- Larrañaga, Igor
- Mar-Barrutia, Lorea
- Soto-Gordoa, Myriam
- SpringerLink (Online service)
Other Objects (12)
Brainstem substructures and cognition in prodromal Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer’s disease from cognitively unimpaired amyloid-positive individuals
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Brainstem substructures and cognition in prodromal Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer’s disease from cognitively unimpaired amyloid-positive individuals
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Brainstem substructures and cognition in prodromal Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer’s disease from cognitively unimpaired amyloid-positive individuals